Q3 2018 13F Holders as of 9/30/2018
-
Type / Class
-
Equity / American Depositary Shares
-
Shares outstanding
-
7.74M
-
Number of holders
-
6
-
Total shares
-
109K
-
Shares change
-
+9.08K
-
Total reported value, excl. options
-
$348K
-
Value change
-
+$29.8K
-
Number of buys
-
3
-
Number of sells
-
-2
-
Price
-
$3.26
Significant Holders of Kazia Therapeutics Limited - American Depositary Shares (KZIA) as of Q3 2018
6 filings reported holding KZIA - Kazia Therapeutics Limited - American Depositary Shares as of Q3 2018.
Kazia Therapeutics Limited - American Depositary Shares (KZIA) has 6 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 109K shares
of 7.74M outstanding shares and own 1.4% of the company stock.
Largest 9 shareholders include MORGAN STANLEY (60.2K shares), RENAISSANCE TECHNOLOGIES LLC (34.3K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (11.1K shares), ACADIAN ASSET MANAGEMENT LLC (2.38K shares), Steward Partners Investment Advisory, LLC (550 shares), BREWIN DOLPHIN LTD (32 shares), ROYAL BANK OF CANADA (0 shares), Carnick & Kubik Group, LLC (106K shares), and UBS Group AG (6.06K shares).
This table shows the top 6 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.